Skip to content
Search

Latest Stories

Pharmacists in England supports idea of 'National Self-Care Strategy', reveals report

A new report based on research from pharmacists across England by Sanofi, has called for the introduction of a ‘national self-care strategy’ to relieve the burden currently faced by health services.

The new report, titled ‘Driving a self-care revolution in the UK’, explores the views of pharmacists, patients and doctors on self-care and the support needed to deliver it more effectively. While self-care policy measures are estimated to increase monetary savings for healthcare systems and national economies by 16%, this report highlights the right tools and resources are not yet in place to enable pharmacists to play a greater role in delivering self-care advice and medicines to patients.


“As many as 77% of pharmacists said they would support the creation of a National Self-Care Strategy to provide national leadership on improving understanding of self-care and encourage its use among both patients and clinicians,” the report said.

According to the report, currently, 33% of pharmacists working for independent or small pharmacy chains do not have the resources to support patients with self-care, alongside their other roles. “To tackle this, close to half (45%) of pharmacists believe greater emphasis by primary care practitioners on the benefits of self-care would leave pharmacists in a better place to support patients. Similarly, 42% believe that training and recruiting more pharmacists would improve their capacity to deliver self-care advice.”

It also highlighted the challenges with access to medicines for pharmacists. The research found that close to a quarter (23%) of pharmacists do not have a broad enough range of over-the-counter medicines to meet needs, meaning they’re not able to provide patients with the correct products.

This figure dramatically increases among the most experienced pharmacists, with 68% of those who have been qualified for more than 15 years agreeing they don’t have access to a broad enough range of over-the-counter medicines.

Because of this, 70% of pharmacists said they would support a review of the Medicines and Healthcare products Regulatory Agency (MHRA) current switching process to determine if improvements can be made that would deliver a better range of over-the-counter medicines for self-care.

For example, 42% of pharmacists would prioritise switching cough, cold and flu medicines from prescription to over-the-counter to ensure they have a wide enough selection of drugs available to support patients with self-care. Similarly, another of the key drug areas this lack of access has been impacting is sexual dysfunction drugs, with 30% of pharmacists saying they would prioritize switching drugs in this category to over-the-counter.

Harsh GK, Managing Director and General Manager, Sanofi UK and Ireland, said: “We all know the NHS is facing unprecedented pressures – everything from an ageing population, ever tighter budgets, and the long-term impact of the COVID-19 pandemic.

“These pressures are felt particularly in primary care, but we’ve seen that many GP appointments are for conditions that can be managed safely and effectively at home, with the help of a pharmacist and medication. As an example, a blocked nose or dandruff.

“More people live within a 20-minute walk of a pharmacy than a GP surgery which highlights the vital role pharmacists can play in reducing the burden on the NHS. It’s clear that pharmacists are becoming ever more important, and we hope this report highlights that with access to the right medicines and information, self-care can – and should – help unlock better health for people.”

Dr Paul Goggin FRPharmS MAPS, Global Head of Switch (Science), Sanofi, said: “This report has highlighted just how important good quality self-care options, such as OTC medications, are. These are vital in ensuring that pharmacists can provide people with the best information and tools to help them self-treat ailments both safely and effectively. The report also shows that health literacy, education and high-quality information provided to patients and practitioners alike is critical. With a broader range of quality self-care options being made available, as well as a greater focus on education, England has a real opportunity to protect and preserve the vital resources of the NHS.”

Michelle Riddalls, Chief Executive, PAGB, the consumer healthcare association, said: “Self-care means something different to everyone, from healthy eating to managing minor ailments and longer-term conditions. This report by Sanofi highlights the breadth of conversations we need to have so everyone – patients and medical professionals alike – understands what self-care can do and the impact it can have.

Understanding self-care is only the start though, and if we want everyone to unlock the benefits of it, we must make sure there is greater access to important over-the-counter medicines so patients can turn to pharmacists and get the support and the help they need both quickly and efficiently.”

The research suggests that pharmacist reimbursement needs to evolve as self-care becomes more critical. Only a quarter (27%) of pharmacists believe the current approach to pharmacist reimbursements reflects the value provided by pharmacists in dispensing self-care, while over a third of pharmacists (35%) believe the Community Pharmacist Consultation Service is not fit for purpose.

Pre-pandemic, some 18 million general practitioner appointments and 3.7 million accident and emergency visits were for minor ailments, at an estimated annual cost of £1.5 billion.Many of these ailments include blocked noses, travel sickness and dandruff which can largely be managed and treated at home successfully, with the support of pharmacists and self-care.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less